Advanced
Product
Solutions
Partners
Resources
Company
Toggle menu
Home
/
Can-Fite BioPharma
Can-Fite BioPharma
Overview
Locations
Financials
Operating Metrics
Human Capital
Key People
Competitors
Supplier Risk
Can-Fite BioPharma
Stock Price
₪0
2024-10-29
Market Capitalization
₪5.5 B
2024-10-29
Revenue
$743 K
FY, 2023
Can-Fite BioPharma Summary
Company Summary
Overview
Can-Fite BioPharma is a biopharmaceutical company with pharmaceutical discovery and clinical development capabilities. It has a pipeline of proprietary compounds that address autoimmune-inflammatory and liver diseases.
Type
Public
Status
Active
Founded
1994
HQ
Petah Tikva, IL
|
view all locations
Website
http://www.canfite.com
Cybersecurity rating
Sectors
Healthcare
biotech
drug development
pharma
Homepage
facebook
twitter
Table of Contents
Key People
Locations
Financials
Competitors
Key People
Ilan Cohn,
Chairman
Pnina Fishman,
Chief Executive Officer, Director
Abraham Sartani,
Director
Locations
View all
1 location detected
Petah Tikva, Center District
HQ
Israel
Bareket St 10, Petah Tikva
Report incorrect company information
Can-Fite BioPharma Financials
Summary Financials
Revenue (H1, 2024)
$316.0K
Gross profit (H1, 2024)
$316.0K
Net income (H1, 2024)
($4.0M)
Cash (H1, 2024)
$4.7M
EBIT (H1, 2024)
($4.1M)
Enterprise value
$5.5B
Competitors and Similar Companies
Alembic Pharmaceuticals
Healthcare - Public
Cipla
Healthcare - Public
Mankind Pharma
Healthcare - Private
UCB
Healthcare - Public
Compare competitors
Footer menu
Contact us
Facebook
Twitter
LinkedIn
Product
Intelligence Suite
Supplier Intelligence Platform
Craft Intelligence Portal
Craft API
Craft for Teams
Supplier Intelligence Platform
Craft Alerts
Craft N-Tier Mapping
Craft Risk Hub
Chrome extension
Solutions
Supplier Intelligence
Sales Intelligence
Aerospace and Defense
Resources
Resource center
Blog
Company
About
Careers
Contact
Terms of Service
Privacy Policy
Security
© Craft.co 2025
Share price data provided by IEX
Back
to top